SIGA TECHNOLOGIES INCSIGA

時価総額
$4.6億
PER
生物脅威対策用医薬品の有力企業。経口・静注抗ウイルス薬TPOXX®を展開、2018年7月にFDA承認。2024年6月に国際販促権をMeridianから再取得、同年国際売上は13カ国で2300万ドル。米国中心に欧州・アジアへ展開、2024年総売上は1.387億ドル。
2011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
現金同等物4932911001132920180161117,890,240103,138,81998,790,622150,145,844155,400,262
有価証券--------------
現金 + 有価証券4932911001132920180161117,890,240103,138,81998,790,622150,145,844155,400,262
売掛金3970,288982,023491,632432243,340,26383,650,45045,406,96021,130,95121,166,129
商品及び製品-1821191226331020,265,51919,510,37939,273,09064,218,33749,563,880
流動資産合計53851241301296937121180143,608,091208,753,092185,786,344238,991,160231,044,884
有形固定資産818,992987,8691831,936449,825299,477138,640171,27432,103,9902,365,9571,848,3141,331,7081,298,423
固定資産合計37217037569210782196,223,3005,973,4839,249,57915,361,69513,292,142
総資産90106194166186161145203199149,831,391214,726,575195,035,923254,352,855244,337,026
買掛金21053431231,278,2172,028,0043,355,2681,456,3161,340,337
一年内返済予定の長期借入金-954,73822----------
流動負債合計7161277147119210,483,51030,487,85821,517,72154,117,74525,331,613
長期借入金-42-----------
固定負債合計42611654054634354618999,554,6129,924,3103,358,1603,376,2033,200,650
総負債497717741347044846810110120,038,12240,412,16824,875,88157,493,94828,532,263
資本金及び資本剰余金5,1645,1645,3105,3515,4117,8697,9048,0768,1277,7207,3547,2687,1097,140
利益剰余金-108,870,309-123,398,462-156,527,870-421,991,008-461,442,332-501,140,292-537,375,776-115,791,261-123,032,408-95,192,881-51,763,255-63,804,993-38,943,622-22,838,012
株主資本422917-246,502,477-284,428,550-287,418,269-323,138,29110398129,793,269174,314,407170,160,042196,858,907215,804,763
有利子負債合計-542----------
純有利子負債--27,107,490-87,350,980-97,723,981-112,711,028---------
DEレシオ(%)-1723.3-0.8----------
運転資本-